newsfilter
← Latest News
Business Wire·

SelectQuote, Inc. Announces Receipt of Continued Listing Standard Notice from NYSE; Plans to Take Appropriate Actions to Cure

SLQT
  • SelectQuote (NYSE: SLQT) received a notice from the NYSE indicating non-compliance with Section 802.01C because its common stock closed below $1.00 per share over a consecutive 30 trading-day period.
  • The company reported strong fiscal second quarter 2026 results on February 5th & executed a new $415 million credit facility extending most debt maturities to 2031.
  • SelectQuote projects fiscal 2026 operating cash flow between $25 million & $35 million & expects continued meaningful cash flow growth.
  • The company has notified the NYSE of its intent to cure the deficiency within a six-month period by achieving a closing price of at least $1.00 for the last trading day of any calendar month during the cure period.
  • Compliance can be regained if the average closing share price remains at least $1.00 over the 30 trading-day period ending on the last trading day of the qualifying month.
  • SelectQuote's stock will continue to be listed & traded on the NYSE during the cure period, subject to compliance with other listing standards.
  • The company plans to monitor its stock price closely & take appropriate actions to maintain its NYSE listing.
  • The release includes forward-looking statements regarding future performance, debt compliance, & listing status that are subject to various risks & uncertainties.
  • SelectQuote operates three core business lines: SelectQuote Senior, SelectQuote Healthcare Services, & SelectQuote Life, within an ecosystem covering insurance, pharmacy, & virtual care.